| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |